Evidence map›Paper›PMID 40948519›Full record

ArticleAmerican journal of cancer research2025

Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancer.

Raviteja Bulusu, Joy Okoro, Esther Frimpong, Sunil Krishnan, Saunjoo Yoon, Bo Han, Xue Zhu, Edward Agyare

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Anti-EGFR liposomal drug delivery system loaded with AGYInternational journal of pharmaceutics: X · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Raviteja BulusuCollege of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University Tallahassee, Florida, USA.
Joy OkoroCollege of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University Tallahassee, Florida, USA.
Esther FrimpongCollege of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University Tallahassee, Florida, USA.
Sunil KrishnanDepartment of Neurosurgery, McGovern Medical School at The University of Texas Health Science Center at Houston Houston, Texas, USA.
Saunjoo YoonDepartment of Biobehavioral Nursing Science, College of Nursing, University of Florida Gainesville, Florida, USA.
Bo HanDepartment of Surgery, Keck School of Medicine, University of Southern California Los Angeles, California, USA.
Xue ZhuCollege of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University Tallahassee, Florida, USA.
Edward AgyareCollege of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University Tallahassee, Florida, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the synthesis, characterization, and therapeutic efficacy of AGY

Indexed as

2D and 3D cell models5-FluorouracilanalogsapoptosisPancreatic cancerWestern blot

Identifiers

PMID40948519
PMCPMC12432553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.